Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + Cisplatin + Radiation in Unresectable Stage IV Head and Neck Cancer
NCT00096174Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Apr 2005
- Primary completion
- Jul 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of KL-140 in head and neck squamous cell carcinoma (HNSCC), sponsored by Eastern Cooperative Oncology Group. Started Apr 2005; status: completed.
02
Drugs
KL-140
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00096174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096174.